INTRODUCTION
============

Nutrition imbalance and physical inactivity due to sedentary life style can lead to obesity, which is closely associated with an increased risk of metabolic syndrome ([@b9-jer-10-2-60-3]; [@b10-jer-10-2-60-3]). Metabolic disorders including insulin resistance and overt type 2 diabetes (T2D) are highly related to secondary cardiovascular complications such as hypertension, myocardial infarction, and stroke ([@b1-jer-10-2-60-3]; [@b52-jer-10-2-60-3]). Adiponectin is one of adipokines secreted from adipose tissue and involved in various biological processes such as energy homeostasis, immune actions, and vascular homeostasis ([@b17-jer-10-2-60-3]; [@b32-jer-10-2-60-3]). A number of clinical observations have demonstrated that circulating levels of adiponectin are markedly reduced in patients with obesity ([@b4-jer-10-2-60-3]), T2D ([@b30-jer-10-2-60-3]), essential hypertension ([@b2-jer-10-2-60-3]), and coronary artery disease (CAD) ([@b47-jer-10-2-60-3]; [@b55-jer-10-2-60-3]). Based on above considerations, therapeutic interventions which can improve the action of adiponectin including elevation of circulating adiponectin concentration or up-regulation and/or activation of its receptors, could provide better understanding of strategies to ameliorate metabolic disorders and vascular disease. The focus of the present review is to summarize accumulating evidence showing the role of interventions such as pharmacological agents, exercise, calorie restriction (CR), and gastric bypass surgery (weight loss) in the expression of adiponectin and adiponectin receptors.

EFFECTS OF INTERVENTIONS ON ADIPONECTIN AND ADIPONECTIN RECEPTORS
=================================================================

Pharmacological/dietary interventions and lifestyle modifications such as exercise and CR to prevent and ameliorate cardiovascular disease and micro-vascular complications in T2D, have been shown to increase circulating levels of adiponectin in both experimental models and human studies ([@b70-jer-10-2-60-3]; [@b81-jer-10-2-60-3]). Up-regulation of endogenous adiponectin and its receptors by interventions might have multiple beneficial effects on metabolic and cardiovascular diseases.

Pharmacological and dietary intervention
----------------------------------------

Peroxisome proliferator-activated receptors (PPARs) are a group of nuclear receptor superfamily which functions as transcription factors regulating gene expression and play important roles in the regulation of cellular differentiation, development, and energy metabolism ([@b67-jer-10-2-60-3]). The three types of PPAR (α, γ, and β/δ) have been identified ([@b67-jer-10-2-60-3]). The PPAR-γ agonists, thiazolidinediones (TZDs) are widely used for anti-diabetic drugs that improve insulin sensitivity through enhancement of glucose disposal as well as reduction of gluconeogenesis in the target tissues of the body including skeletal muscle, liver, and adipose tissue ([@b28-jer-10-2-60-3]; [@b39-jer-10-2-60-3]). A number of studies have shown that TZDs such as rosiglitazone and pioglitazone increased circulating levels of adiponectin in both human and experimental rodent models ([@b19-jer-10-2-60-3]; [@b34-jer-10-2-60-3]; [@b46-jer-10-2-60-3]; [@b60-jer-10-2-60-3]). In addition to PPAR-γ, the PPAR-α agonist induced the increase in the circulating level of adiponectin associated with improvement in insulin sensitivity. For example, fenofibrate an agonist of nuclear receptor PPAR-α, increased serum levels of adiponectin in patients with primary hypertriglyceridemia ([@b41-jer-10-2-60-3]). Previous studies have implicated that hypoadiponectinemia is associated with hypertension ([@b2-jer-10-2-60-3]; [@b61-jer-10-2-60-3]). Therefore, it is tempting to speculate whether anti-hypertensive drugs such as candesartan and losartan (angiotensin II receptor antagonists) increase adiponectin. These drugs, indeed, elevated circulating adiponectin without altering adiposity ([@b15-jer-10-2-60-3]; [@b29-jer-10-2-60-3]; [@b42-jer-10-2-60-3]; [@b43-jer-10-2-60-3]). In addition, several other drugs for anti-diabetic (glimepiride) and anti-hypertension (nebivolol, β~1~ receptor blocker) have been shown to enhance plasma adiponectin concentrations in human subjects ([@b15-jer-10-2-60-3]; [@b54-jer-10-2-60-3]). However, it is unclear whether elevated adiponectin is associated with improved cardiovascular outcomes.

In addition to pharmacological agents, dietary fish oils (FO) and polyunsaturated fatty acids (PUFA) have been shown to increase mRNA expression of adiponectin in adipose tissue and circulating levels of adiponectin in several experimental models and human ([@b53-jer-10-2-60-3]; [@b56-jer-10-2-60-3]; [@b65-jer-10-2-60-3]). Furthermore, Oolong tea, green tea extract and (-)-catechin increased plasma adiponectin in humans and rodent models ([@b18-jer-10-2-60-3]; [@b49-jer-10-2-60-3]; [@b69-jer-10-2-60-3]). [Table 1](#t1-jer-10-2-60-3){ref-type="table"} summarized the effects of pharmacological agents and dietary intervention on the expression of adiponectin.

Exercise
--------

It is well documented that exercise or regular physical activity has beneficial effects on metabolic and cardiovascular disease. Considering previous literatures, it is unclear whether exercise training (physical activity) increases adiponectin in circulation and its receptors in insulin-sensitive tissues such as adipose tissue, liver, and skeletal muscle. Complicating interpretation of the existing data is dependent on multiple factors including species, the pathological condition, types (endurance vs resistance exercise), intensity (low, moderate, and intense), and duration of exercise (acute vs chronic, short-term vs long-term), and sex. For example, in healthy, young subjects, it seemed that both acute and chronic aerobic exercise did not alter plasma level of adiponectin ([@b26-jer-10-2-60-3]; [@b33-jer-10-2-60-3]; [@b38-jer-10-2-60-3]; [@b64-jer-10-2-60-3]). However, chronic endurance training increased plasma adiponectin in obese adolescents ([@b5-jer-10-2-60-3]), obese adults ([@b44-jer-10-2-60-3]), Caucasian subjects with impaired glucose tolerance (IGT) and T2D ([@b6-jer-10-2-60-3]; [@b58-jer-10-2-60-3]). Furthermore, endurance training increased mRNA expression of adiponectin receptor (AdipoR) 1 and 2 in adipose tissue and skeletal muscle in normal glucose tolerance (NGT), IGT, and type 2 diabetic patients ([@b6-jer-10-2-60-3]; [@b7-jer-10-2-60-3]; [@b58-jer-10-2-60-3]). On the other hand, some studies by several other groups have shown that aerobic exercise did not change adiponectin expression in obese subject ([@b63-jer-10-2-60-3]), insulin resistant female subjects ([@b50-jer-10-2-60-3]), and patients with T2D ([@b11-jer-10-2-60-3]; [@b79-jer-10-2-60-3]). Interestingly, Fatouros et al. have demonstrated that only moderate-high intensity resistance training, not low intensity, increased plasma adiponectin in inactive subjects, suggesting that the intensity of exercise may be an important factor in the expression of adiponectin ([@b24-jer-10-2-60-3]). [Table 2](#t2-jer-10-2-60-3){ref-type="table"} shows a summary of studies examining effects of exercise training on adiponectin and AdipoRs in both human and experimental models.

Calorie restriction, weight loss, and gastric bypass surgery
------------------------------------------------------------

Calorie restriction (CR) refers to a dietary regimen low in calories without malnutrition and is known as an efficient lifestyle modification that delays the onset of metabolic and cardiovascular disease ([@b14-jer-10-2-60-3]). Weight loss and/or CR have been shown to improve insulin resistance, T2D, and cardiovascular dysfunction in both human and rodent models ([@b74-jer-10-2-60-3]). In addition, sustained weight loss by gastric bypass surgery ameliorated cardiovascular dysfunction ([@b13-jer-10-2-60-3]; [@b80-jer-10-2-60-3]). Although it is not clear whether beneficial effects of these interventions are mediated by adiponectin signaling pathways, a number of studies have shown that CR and/or weight loss by gastric bypass surgery increased circulating levels of adiponectin. For example, CR increased circulating adiponectin in normal ([@b27-jer-10-2-60-3]; [@b68-jer-10-2-60-3]) and obese subjects ([@b40-jer-10-2-60-3]; [@b59-jer-10-2-60-3]; [@b71-jer-10-2-60-3]). However, some studies have shown that CR did not change plasma levels of adiponectin in patients with metabolic syndrome ([@b77-jer-10-2-60-3]) and T2D ([@b62-jer-10-2-60-3]). Interestingly, [@b72-jer-10-2-60-3] have implicated that circulating adiponectin concentration increased 20% in the 5--10% weight loss group, not less than 5% weight loss group, suggesting a minimum degree of weight loss are required to improve adipokine profile in severely obese women. On the other hand, Plum et al. suggested that Roux-en-Y gastric bypass surgery, not low calorie diet group, increased plasma adiponectin concentration in patients with T2D, although weight loss was comparable in both groups ([@b62-jer-10-2-60-3]). This may suggest that Roux-en-Y gastric bypass surgery is more effective method than low calorie diet regimen in some kinds of obese diabetic patients. Because metabolic and cardiovascular diseases are multi-factorial phenomena, we need to consider the effect of other metabolic disorders such as dyslipidemia, hypercholesterolemia, and hypertension on the expression of adiponectin. [Table 3](#t3-jer-10-2-60-3){ref-type="table"} summarizes the effects of CR, weight loss and gastric bypass surgery on adiponectin.

CONCLUSIONS
===========

There is no doubt that pharmacological agents and lifestyle modifications affect metabolic and cardiovascular disease. In regard to the expression of adiponectin and its receptors with these interventions, it remains unclear whether these interventions ameliorate metabolic and cardiovascular dysfunction through adiponectin and its receptors-mediated signaling pathways. Recent studies provide compelling evidence supporting the beneficial role of adiponectin in the metabolic and cardiovascular diseases. Although significant progress has made in understanding the molecular mechanisms that underlie the beneficial actions of adiponectin, it should be noted that large discrepancies exist among those studies based on experimental design including species, type of intervention, and the pathological condition. Further investigations in adiponectin signaling pathways will provide potential targets used for the therapeutic interventions in metabolic and cardiovascular disease.
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###### 

Effects of pharmacological agents and dietary intervention on adiponectin

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Subject or animal                                  Sex      Pharmacological agents                     Duration       Methods for intake   Tissues                     Methods    Conclusions       References
  -------------------------------------------------- -------- ------------------------------------------ -------------- -------------------- --------------------------- ---------- ----------------- ----------------------
  Non-diabetic patients                              Female   -Pioglitazone (1--3 μM)                    24 h           Cell culture         Subcutaneous fat (Biopsy)   PCR\       = APN ↑ HMW APN   [@b8-jer-10-2-60-3]
                                                                                                                                                                         WB                           

  Normal volunteers                                  Male     -Rosiglitazone (4 mg twice/daily)          2 wk           Oral intake          Serum sedimentation         Velocity   ↑ Total APN\      [@b60-jer-10-2-60-3]
                                                                                                                                                                                    ↑ HMW APN         

  Healthy normal weight subjects                     Both     -Flaxseed oil (15 mL/day)\                 6 wk           Oral intake          Plasma                      ELISA      = APN\            [@b45-jer-10-2-60-3]
                                                              -Olive oil (15 mL/day)                                                                                                = APN             

  Patients with primary hypertriglyceridemia         Both     -Fenofibrate (200 mg daily)                8 wk           Oral intake          Serum                       ELISA      ↑ APN             [@b41-jer-10-2-60-3]

  Patients with hypercholes terolemic hypertension   Both     -Simvastatin (20 mg) +Losartan (100 mg)\   2 mo           Oral intake          Plasma                      ELISA      ↑ APN\            [@b42-jer-10-2-60-3]
                                                              -Losartan only (100 mg/daily)                                                                                         ↑ APN             

  Patients with essential hypertension               Both     -Temocapril (4 mg/daily)\                  2 wk           Oral intake          Serum                       ELISA      ↑ APN\            [@b29-jer-10-2-60-3]
                                                              -Candesartan (8 mg/daily)                                                                                             ↑ APN             

  Patients with mild to moderate hypertension        Both     -Candesartan (16 mg/daily)                 2 mo           Oral intake          Plasma                      ELISA      ↑ APN             [@b43-jer-10-2-60-3]

  Patients with hypertension                         Both     -Nebivolol (5 mg/daily)\                   6 mo           Oral intake          Plasma                      ELISA      ↑ APN\            [@b15-jer-10-2-60-3]
                                                              -Metoprolol (100 mg/daily)                                                                                            = APN             

  Patients with T2D                                  Both     -Glimepiride (1.9 mg/daily)\               3 mo           Oral intake          Serum                       ELISA      ↑ APN\            [@b54-jer-10-2-60-3]
                                                              -Metformin (750 mg/daily)                                                                                             ↑ APN             

  Patients with CAD                                  Both     -Oolong tea (1,000 mL) vs. water           1 mo           Oral intake          Plasma                      ELISA      ↑ APN             [@b69-jer-10-2-60-3]

  Patients with CAD                                  Both     -Omega-3 PUFA                              4 wk           Oral intake          Plasma                      ELISA      ↑ APN             [@b53-jer-10-2-60-3]

  Rats (OLETF)                                       Male     -Rosiglitazone (2 mg/kg/day)\              40 wk          In food              Serum                       ELISA      ↑ APN\            [@b19-jer-10-2-60-3]
                                                              -Fenofibrate (100 mg/kg/day)                                                                                          = APN             

  Rats (Wistar)                                      Male     -Sucrose Rich Diet\                        9 mo           In food              Plasma                      ELISA      ↓ APN\            [@b65-jer-10-2-60-3]
                                                              -Sucrose Rich Diet (7 mo)+FO Diet (2 mo)                                                                              ↑ APN             

  Hamsters (Golden Syrian)                           Male     -Green tea extract (low dose 150 mg/kg)\   4 wk           Oral gavage          Plasma                      ELISA      ↑ APN\            [@b49-jer-10-2-60-3]
                                                              -Green tea extract (high dose 300 mg/kg)                                                                              ↑ APN             

  Hamsters (Golden Syrian)                           Male     -Niacin (1,200 mg/kg)                      18 days        Oral gavage          AT                          PCR        ↑ APN             [@b20-jer-10-2-60-3]

  Mice (ob/ob)                                       Male     -Pioglitazone (10 mg/kg)\                  2 wk           Oral gavage          Serum                       ELISA      ↑ APN\            [@b46-jer-10-2-60-3]
                                                              -Pioglitazone (30 mg/kg)                                                                                              ↑↑ APN            

  Mice (db/db)                                       Male     -Troglitazone (0.2%)\                      2 wk           In food              Subcutaneous AT\            PCR\       ↑ APN\            [@b34-jer-10-2-60-3]
                                                              -Pioglitazone (0.01%)                                                          Serum                       WB         ↑ APN             

  Mice (db/db)                                       Male     -Rosiglitazone (10 mg/kg)                  11 days        Oral gavage          Serum sedimentation         Velocity   = Total APN\      [@b60-jer-10-2-60-3]
                                                                                                                                                                                    ↑ HMW APN         

  Mice (129 Sv)                                      Male     −27% Fish oil                              8 or 15 days   In food              Plasma\                     ELISA\     ↑ APN\            [@b56-jer-10-2-60-3]
                                                                                                                                             Epididymal AT\              PCR\       ↑ APN\            
                                                                                                                                             Subcutaneous AT             PCR        = APN             

  Mice (3T3-L1 adipocytes)                           \-       (-)-catechin (50 μM)\                      24 h           Cell culture         Adipocytes                  WB\        ↑ APN\            [@b18-jer-10-2-60-3]
                                                              (-)-catechin (5--100 μM)\                                                                                  ELISA\     ↑ APN\            
                                                              (-)-catechin (50 μM)                                                                                       PCR        ↑ APN             
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

APN, adiponectin; AT, adipose tissue; CAD, coronary artery disease; db/db, leptin receptor mutated mouse; ELISA, enzyme linked immunosorbent assay; FO, fish oil; HMW, high molecular weight; OLETF rat, Otsuka Long-Evans Tokushima fatty rat; ob/ob, leptin deficient mouse; PCR, polymerase chain reaction; PUFA, polyunsaturated fatty acid; T2D, type 2 diabetes; WB, western blotting; ↑, increase; ↓, decrease; =, no change.

###### 

Effects of exercise on adiponectin and adiponectin receptors

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Subject or animal                              Sex      Type of exercise                                                    Duration                       Tissues                 Methods   Conclusions                                       References
  ---------------------------------------------- -------- ------------------------------------------------------------------- ------------------------------ ----------------------- --------- ------------------------------------------------- ----------------------
  Healthy subjects                               Both     Cycle ergometry training                                            60 min (Acute)                 Plasma                  ELISA     = APN                                             [@b26-jer-10-2-60-3]

  Healthy subjects                               Both     Aerobic training                                                    6 mo (4 days/wk)               Plasma                  ELISA     = APN                                             [@b33-jer-10-2-60-3]

  Healthy non-obese subjects                     Male     Ergometer training                                                  6 wk (5 days/wk)               Serum                   ELISA     ↓ APN (At 16 h after the last training session)   [@b78-jer-10-2-60-3]

  Young subjects                                 Male     Cycle ergometer                                                     2 h (Acute)                    Plasma                  ELISA     = APN                                             [@b64-jer-10-2-60-3]

  Highly-trained young rowers                    Male     Rowing ergometer                                                    Maximal 6,000 m test (Acute)   Plasma                  ELISA     ↑ APN (After 30 min of recovery)                  [@b37-jer-10-2-60-3]

  Highly-trained young rowers                    Male     Training for rowers                                                 6 mo                           Plasma                  ELISA     = APN                                             [@b38-jer-10-2-60-3]

  Inactive subjects                              Male     Resistance training (low, moderate, high intensity)                 6 mo (3 days/wk)               Plasma                  ELISA     = APN (low intensity)\                            [@b24-jer-10-2-60-3]
                                                                                                                                                                                               ↑ APN (moderate)\                                 
                                                                                                                                                                                               ↑ APN (high)                                      

  Young overweight subjects                      Male     Cycle ergometer                                                     45 min (Acute)                 Plasma                  ELISA     = APN (Post 24, 48 h)                             [@b35-jer-10-2-60-3]

  Obese subjects                                 Both     Aerobic exercise + hypo-caloric (ExHypo) or eucoloric (ExEu) diet   12 wk (5 days/wk)              Serum\                  ELISA\    ↑ HMW/Total APN\                                  [@b57-jer-10-2-60-3]
                                                                                                                                                             Skeletal muscle         PCR       ↑ AdipoR1 and 2                                   

  Obese subjects                                 Female   Aerobic exercise (Bicycle ergometer)                                12 wk (5 days/wk)              Plasma SCAAT (biopsy)   ELISA\    = APN\                                            [@b63-jer-10-2-60-3]
                                                                                                                                                                                     PCR       = APN                                             

  Obese subjects                                 Female   Endurance training                                                  7 mo (4--5 days/wk)            Plasma                  ELISA     ↑ APN                                             [@b44-jer-10-2-60-3]

  Obese adolescents                              Both     Aerobic activities                                                  3 mo (3 days/wk)               Plasma                  ELISA     ↑ APN                                             [@b5-jer-10-2-60-3]

  Middle-aged subjects with insulin resistance   Both     Aerobic exercise (moderate to intense)                              16 wk (5 days/wk)              Plasma                  ELISA     = APN                                             [@b50-jer-10-2-60-3]

  Caucasian subjects with NGT, IGT, and T2D      Both     Physical training                                                   4 wk (3 days/wk)               Serum Skeletal muscle   ELISA\    ↑ APN\                                            [@b6-jer-10-2-60-3]
                                                                                                                                                                                     PCR       ↑ AdipoR1 and 2                                   

  Caucasian subjects with NGT, IGT, and T2D      Both     Physical training                                                   4wk (3 days/wk)                Subcutaneous AT\        PCR\      ↑ AdipoR1 and 2\                                  [@b7-jer-10-2-60-3]
                                                                                                                                                             Skeletal muscle         PCR       ↑ AdipoR1 and 2                                   

  Caucasian subjects with NGT, IGT, and T2D      Both     Physical training program (Aerobic + Power training)                4 wk (3 days/wk)               Plasma                  ELISA     = APN in NGT\                                     [@b58-jer-10-2-60-3]
                                                                                                                                                                                               ↑ APN in IGT\                                     
                                                                                                                                                                                               ↑ APN in T2D                                      

  Caucasian subjects with NGT, IGT, and T2D      Both     Physical training (Aerobic exercise)                                4 wk (3 days/wk)               Plasma\                 ELISA\    ↑ APN in NGT, IGT and T2D\                        [@b6-jer-10-2-60-3]
                                                                                                                                                             Skeletal muscle         PCR       ↑ AdipoR1 and 2 in NGT, IGT, and T2D              

  Patients with T2D                              Both     Aerobic exercise (walking and bicycle ergometer)                    3 wk (5 days/wk)               Plasma                  ELISA     = APN                                             [@b79-jer-10-2-60-3]

  Middle-aged subjects with T2D                  Male     Endurance training                                                  8 wk (3 days/wk)               Plasma                  ELISA     = APN                                             [@b11-jer-10-2-60-3]

  Older, healthy subjects                        Both     Aerobic and resistance exercise training                            12 wk (3 days/wk)              Serum                   ELISA     ↑ APN                                             [@b51-jer-10-2-60-3]

  Rats (SD)                                      Male     Endurance training                                                  6 mo (5 days/wk)               Serum\                  ELISA\    ↑ APN\                                            [@b21-jer-10-2-60-3]
                                                                                                                                                             Skeletal muscle\        PCR\      ↑ APN\                                            
                                                                                                                                                             Adipose\                PCR\      = APN\                                            
                                                                                                                                                             Skeletal muscle\        WB\       ↑ APN\                                            
                                                                                                                                                             Adipose                 WB        ↑ APN                                             

  Mice (Swiss)                                   Male     Swimming exercise                                                   12 wk (5 days/wk)              Adipose\                WB        ↑ AdipoR1\                                        [@b23-jer-10-2-60-3]
                                                                                                                                                             Liver\                            ↑ AdipoR1\                                        
                                                                                                                                                             Skeletal muscle                   ↑ AdipoR1                                         

  Mice (db/db)                                   Male     Endurance training                                                  10 wk (5 days/wk)              Serum                   ELISA     ↑ APN                                             [@b48-jer-10-2-60-3]

  Mice (KKAy)                                    Male     Endurance training                                                  8 wk (5 days/wk)               Skeletal muscle\        PCR       ↑ AdipoR1\                                        [@b31-jer-10-2-60-3]
                                                                                                                                                             Skeletal muscle\                  = AdipoR2\                                        
                                                                                                                                                             Liver\                            ↑ AdipoR1\                                        
                                                                                                                                                             Liver\                            ↓ AdipoR1\                                        
                                                                                                                                                             White adipose\                    = AdipoR1\                                        
                                                                                                                                                             White adipose                     = AdipoR1                                         

  Mice (C57BL/6)                                 Male     Voluntary wheel running                                             6 wk                           Plasma                  ELISA     = APN                                             [@b12-jer-10-2-60-3]
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AdipoR, adiponectin receptor; APN, adiponectin; AT, adipose tissue; SCAAT, subcutaneous abdominal adipose tissue; db/db, leptin receptor mutated mouse; ELISA, enzyme linked immunosorbent assay; HMW, high molecular weight; IGT, impaired glucose tolerance; NGT, normal glucose tolerance; PCR, polymerase chain reaction; SD, Sprague Dawley; T2D, type 2 diabetes; WB, western blotting; ↑, increase; ↓, decrease; =, no change.

###### 

Effects of calorie restriction (CR), weight loss, and gastric bypass surgery on adiponectin

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Subject or animal                        Sex      Type of treatment                                                       Duration   Tissues            Methods   Conclusions                  References
  ---------------------------------------- -------- ----------------------------------------------------------------------- ---------- ------------------ --------- ---------------------------- ----------------------
  Normal subjects                          Both     CR                                                                      ≤ 7 yr     Serum              ELISA     ↑ APN                        [@b27-jer-10-2-60-3]

  Normal weight subjects                   Female   CR (1,000--1,200 kcal/day)                                              4 wk       Plasma             ELISA     ↓ APN                        [@b76-jer-10-2-60-3]

  Caucasian subjects                       Male     CR\                                                                     12 wk      Serum              ELISA     ↑ APN                        [@b68-jer-10-2-60-3]
                                                    (low calorie diet, 800 kcal/day)                                                                                                             

  Obese subjects                           Both     CR program                                                              3 mo       Plasma             ELISA     ↑ HMW APN\                   [@b40-jer-10-2-60-3]
                                                                                                                                                                    ↓ hexamer APN\               
                                                                                                                                                                    ↓ trimer APN                 

  Obese subjects                           Female   CR (↓ 600 kcal/day)                                                     5--6 mo    Adipose\           PCR\      ↑ APN\                       [@b66-jer-10-2-60-3]
                                                                                                                                       Adipose\           ELISA\    ↑ APN\                       
                                                                                                                                       Plasma\            ELISA\    = Total APN\                 
                                                                                                                                       Adipose\           WB\       ↑ HMW APN\                   
                                                                                                                                       Adipose\           WB\       = MMW APN\                   
                                                                                                                                       Adipose            WB        ↓ LMW APN                    

  Obese subjects                           Both     CR (weight loss, very low caloric diet)                                 12 wk      Serum              ELISA     ↑ APN                        [@b59-jer-10-2-60-3]

  Obese subjects                           Female   CR (very low calorie diet)                                              3 wk       Serum              ELISA     = APN                        [@b3-jer-10-2-60-3]

  Severely obese subjects                  Female   CR (low-calorie diet, less than 5% weight loss or 5--10% weight loss)   3 wk       Plasma             ELISA     = APN (less than 5%)\        [@b72-jer-10-2-60-3]
                                                                                                                                                                    ↑ APN (5--10% weight loss)   

  Obese subjects with metabolic syndrome   Both     CR (very low-calorie diet)                                              12 mo      Plasma             ELISA     = APN                        [@b77-jer-10-2-60-3]

  Patients with T2D                        Both     Low calorie diet Roux-en-Y gastric bypass                               3 mo       Plasma             ELISA     = APN\                       [@b62-jer-10-2-60-3]
                                                                                                                                                                    ↑ APN                        

  Rats (F344/NSIc)                         Male     CR                                                                      4 wk       Plasma             ELISA     = HMW APN                    [@b62-jer-10-2-60-3]

  Rats (SD)                                Male     CR (40%)                                                                6 mo       Serum\             ELISA\    ↑ APN\                       [@b21-jer-10-2-60-3]
                                                                                                                                       Skeletal muscle\   PCR\      ↑ APN\                       
                                                                                                                                       Adipose\           PCR\      ↑ APN\                       
                                                                                                                                       Skeletal muscle\   WB\       ↑ APN\                       
                                                                                                                                       Adipose            WB        ↑ APN                        

  Rats (SD)                                Male     CR (40%)                                                                26 wk      Serum              ELISA     ↑ APN                        [@b16-jer-10-2-60-3]

  Rats (SHRs)                              Male     CR                                                                      5 wk       Plasma             ELISA     ↑ APN                        [@b16-jer-10-2-60-3]

  Mice (C57BL/6)                           Female   CR                                                                      8 wk       Serum              ELISA     ↑ APN                        [@b75-jer-10-2-60-3]

  Mice (C57BL/6N)                          Female   CR (30% caloric-restricted diet)                                        10 wk      Serum              ELISA     ↑ APN                        [@b25-jer-10-2-60-3]

  Mice (C57BL/6J)                          Female   CR Alternate-day fasting                                                4 wk       Plasma             ELISA     ↑ APN\                       [@b71-jer-10-2-60-3]
                                                                                                                                                                    ↑ APN                        

  Mice (C57BL/6)                           Male     CR                                                                      8 wk       Plasma             ELISA     ↑ APN                        [@b73-jer-10-2-60-3]
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

APN, adiponectin; CR, calorie restriction; ELISA, enzyme linked immunosorbent assay; HMW, high molecular weight; LMW, low molecular weight; MMW, medium molecular weight; PCR, polymerase chain reaction; SD, Sprague Dawley; T2D, type 2 diabetes; SHRs, spontaneously hypertensive rats; WB, western blotting; ↑, increase; ↓, decrease; =, no change.
